217 related articles for article (PubMed ID: 23082123)
1. Treating and preventing influenza in aged care facilities: a cluster randomised controlled trial.
Booy R; Lindley RI; Dwyer DE; Yin JK; Heron LG; Moffatt CR; Chiu CK; Rosewell AE; Dean AS; Dobbins T; Philp DJ; Gao Z; MacIntyre CR
PLoS One; 2012; 7(10):e46509. PubMed ID: 23082123
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis.
Ye M; Jacobs A; Khan MN; Jaipaul J; Oda J; Johnson M; Doroshenko A
BMJ Open; 2016 Jul; 6(7):e011686. PubMed ID: 27381211
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care.
Dronavalli M; Lord H; Alexander K; Boonwaat L; Pal N; Fletcher-Lartey SM
J Epidemiol Glob Health; 2020 Jun; 10(2):184-189. PubMed ID: 32538036
[TBL] [Abstract][Full Text] [Related]
4. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Parker R; Loewen N; Skowronski D
Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
[TBL] [Abstract][Full Text] [Related]
5. Neuraminidase inhibitors for preventing and treating influenza in children.
Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
[TBL] [Abstract][Full Text] [Related]
6. The use of oseltamivir during an influenza B outbreak in a chronic care hospital.
Seale H; Weston KM; Dwyer DE; Zhu M; Allchin L; Booy R; MacIntyre CR
Influenza Other Respir Viruses; 2009 Jan; 3(1):15-20. PubMed ID: 19453437
[TBL] [Abstract][Full Text] [Related]
7. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000.
Bowles SK; Lee W; Simor AE; Vearncombe M; Loeb M; Tamblyn S; Fearon M; Li Y; McGeer A;
J Am Geriatr Soc; 2002 Apr; 50(4):608-16. PubMed ID: 11982659
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses.
Doll MK; Winters N; Boikos C; Kraicer-Melamed H; Gore G; Quach C
J Antimicrob Chemother; 2017 Nov; 72(11):2990-3007. PubMed ID: 28961794
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir prophylaxis in controlling influenza outbreak in nursing homes: a comparison between three different approaches.
Gorišek Miksić N; Uršič T; Simonović Z; Lusa L; Lobnik Rojko P; Petrovec M; Strle F
Infection; 2015 Feb; 43(1):73-81. PubMed ID: 25403263
[TBL] [Abstract][Full Text] [Related]
10. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
Beigel JH; Bao Y; Beeler J; Manosuthi W; Slandzicki A; Dar SM; Panuto J; Beasley RL; Perez-Patrigeon S; Suwanpimolkul G; Losso MH; McClure N; Bozzolo DR; Myers C; Holley HP; Hoopes J; Lane HC; Hughes MD; Davey RT;
Lancet Infect Dis; 2017 Dec; 17(12):1255-1265. PubMed ID: 28958678
[TBL] [Abstract][Full Text] [Related]
12. Influenza outbreaks in aged care facilities in New South Wales in 2017: impact and lessons for surveillance.
Merritt TD; Dalton CB; Kakar SR; Ferson MJ; Stanley P; Gilmour RE
Commun Dis Intell (2018); 2021 Apr; 45():. PubMed ID: 33934695
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
Jefferson T; Jones M; Doshi P; Del Mar C
BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
[TBL] [Abstract][Full Text] [Related]
14. The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long-term care facilities in Manitoba, Canada, 2014-2015: a retrospective cohort study.
Singh D; Jiang D; Van Caeseele P; Loeppky C
Infect Control Hosp Epidemiol; 2018 Aug; 39(8):955-960. PubMed ID: 29893659
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir in influenza outbreaks in care homes: challenges and benefits of use in the real world.
Millership S; Cummins A
J Hosp Infect; 2015 Aug; 90(4):299-303. PubMed ID: 26071039
[TBL] [Abstract][Full Text] [Related]
17. Observations on managing an outbreak of influenza A infection in an aged care facility.
McCall BJ; Mohr CM; Jarvinen KA
Commun Dis Intell Q Rep; 2007 Dec; 31(4):410-2. PubMed ID: 18268884
[TBL] [Abstract][Full Text] [Related]
18. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
Vu D; Peck AJ; Nichols WG; Varley C; Englund JA; Corey L; Boeckh M
Clin Infect Dis; 2007 Jul; 45(2):187-93. PubMed ID: 17578777
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir for control of influenza at mass gatherings.
Tashani M; Rashid H; Ridda I; Heron L; Memish ZA; Haworth E; Booy R
Infect Disord Drug Targets; 2013 Feb; 13(1):46-52. PubMed ID: 23675926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
